Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine as Therapy in Untreated and Relapsed Waldenstrom's Macroglobulinemia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Journal
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume 11, Issue 1, Pages 130-132Publisher
CIG MEDIA GROUP, LP
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Managing Waldenstrom's macroglobulinemia with BTK inhibitors
Christian Buske, Wojciech Jurczak, Joe-Elie Salem, Meletios A. Dimopoulos
LEUKEMIA (2023)
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenstrom's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study
Marie Jose Kersten, Karima Amaador, Monique C. Minnema, Josephine M. I. Vos, Kazem Nasserinejad, Marcel Kap, Efstathios Kastritis, Maria Gavriatopoulou, Willem Kraan, Martine E. D. Chamuleau, Dries Deeren, Lidwine W. Tick, Jeanette K. Doorduijn, Fritz Offner, Lara H. Boehmer, Roberto D. Liu, Steven T. Pals, Meletios A. Dimopoulos
JOURNAL OF CLINICAL ONCOLOGY (2022)
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim M. Linton, Martine E. D. Chamuleau, David John Lewis, Anna Sureda Balari, David Cunningham, Roberto S. Oliveri, Brian Elliott, Dena DeMarco, Ada Azaryan, Christopher Chiu, Tommy Li, Kuo-mei Chen, Tahamtan Ahmadi, Pieternella J. Lugtenburg
LANCET (2021)
Cytogenetic and molecular abnormalities in Waldenstrom's macroglobulinemia patients: Correlations and prognostic impact
Daphne Krzisch, Nayara Guedes, Clementine Boccon-Gibod, Marine Baron, Clotilde Bravetti, Frederic Davi, Marine Armand, Luce Smagghe, Jonathan Caron, Olivier A. Bernard, Santos Susin, Elise Chapiro, Veronique Leblond, Florence Nguyen-Khac, Damien Roos-Weil
AMERICAN JOURNAL OF HEMATOLOGY (2021)
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia
Panayiotis Panayiotidis, Gayane Tumyan, Catherine Thieblemont, Vadim V. Ptushkin, Ana Marin-Niebla, Ramon Garcia-Sanz, Steven Le Gouill, Anastasios Stathis, Alessia Bottos, Habib Hamidi, Pablo Katz, Thomas Perretti, Jenna C. Willis, Christian Buske
LEUKEMIA & LYMPHOMA (2022)
Dutch Physician's Perspectives on Diagnosis and Treatment of Waldenstrom's Macroglobulinemia Before and After the Implementation of a National Guideline
Karima Amaador, Marie Jose Kersten, Monique C. Minnema, Josephine M. I. Vos
HEMASPHERE (2022)
Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenstrom's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study
Xin-Xin Cao, Jie Jin, Cheng-Cheng Fu, Shu-Hua Yi, Wei-Li Zhao, Zi-Min Sun, Wei Yang, Deng-Ju Li, Guo-Hui Cui, Jian-da Hu, Ting Liu, Yong-Ping Song, Bing Xu, Zun-Min Zhu, Wei Xu, Ming-Zhi Zhang, Ya-Min Tian, Bin Zhang, Ren-Bin Zhao, Dao-Bin Zhou
ECLINICALMEDICINE (2022)
First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenstrom's Macroglobulinemia: A systematic review and meta-analysis
Hassan Abushukair, Sebawe Syaj, Obada Ababneh, Aref Qarqash, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Ibrutinib plus rituximab for the treatment of adult patients with Waldenstrom's macroglobulinemia: a safety evaluation
Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou, Meletios Athanasios Dimopoulos
EXPERT OPINION ON DRUG SAFETY (2021)
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenstrom macroglobulinemia
Cecile Tomowiak, Stephanie Poulain, Charles Herbaux, Aurore Perrot, Beatrice Mahe, Pierre Morel, Therese Aurran, Olivier Tournilhac, Stephane Lepretre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, Delphine Nollet, Damien Roos-Weil, Sylvie Chevret, Veronique Leblond
BLOOD ADVANCES (2021)
Managing complications secondary to Waldenstrom's macroglobulinemia
Ilias Pessach, Meletios A. Dimopoulos, Efstathios Kastritis
EXPERT REVIEW OF HEMATOLOGY (2021)
Report of Consensus Panel 6 from the 11 th International Workshop on Waldenstrom's Macroglobulinemia on Management of Waldenstrom's Macroglobulinemia Related Amyloidosis
Giampaolo Merlini, Shayna Sarosiek, Giulia Benevolo, Xinxin Cao, Meletios Dimopoulos, Ramon Garcia-Sanz, Moshe E. Gatt, Carlos Fernandez de Larrea, Jesus San-Miguel, Steven P. Treon, Monique C. Minnema
SEMINARS IN HEMATOLOGY (2023)
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie Jose Kersten, Charalambos Andreadis, Peter A. Riedell, P. Joy Ho, Jose Antonio Perez-Simon, Andy Chen, Loretta J. Nastoupil, Bastian von Tresckow, Andres Jose Maria Ferreri, Takanori Teshima, Piers E. M. Patten, Joseph P. McGuirk, Andreas L. Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Aiesha Zia, Rakesh Awasthi, Aisha Masood, Oezlem Anak, Stephen J. Schuster, Catherine Thieblemont
NATURE MEDICINE (2022)
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenstrom's macroglobulinemia
Christian Buske, Alessandra Tedeschi, Judith Trotman, Ramon Garcia-Sanz, David MacDonald, Veronique Leblond, Beatrice Mahe, Charles Herbaux, Jeffrey Matous, Constantine S. Tam, Leonard T. Heffner, Marzia Varettoni, M. Lia Palomba, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jerry Ping, Bernhard Hauns, Israel Arango-Hisijara, Meletios A. Dimopoulos
FUTURE ONCOLOGY (2023)
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004) a multicentre, open-label, single-arm, phase 1-2 study & nbsp;
Tanya Siddiqi, David G. Maloney, Saad S. Kenderian, Danielle M. Brander, Kathleen Dorritie, Jacob Soumerai, Peter A. Riedell, Nirav N. Shah, Rajneesh Nath, Bita Fakhri, Deborah M. Stephens, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Serena K. Perna, Sherilyn A. Tuazon, San -San Ou, Eniko Papp, Leanne Peiser, Yizhe Chen, William G. Wierda
LANCET (2023)
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
Paola Ulivi, Milena Urbini, Elisabetta Petracci, Matteo Canale, Alessandra Dubini, Daniela Bartolini, Daniele Calistri, Paola Cravero, Eugenio Fonzi, Giovanni Martinelli, Ilaria Priano, Kalliopi Andrikou, Giuseppe Bronte, Lucio Crino, Angelo Delmonte
CANCERS (2022)
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer
Lucia Mazzotti, Anna Gaimari, Sara Bravaccini, Roberta Maltoni, Claudio Cerchione, Manel Juan, Europa Azucena-Gonzalez Navarro, Anna Pasetto, Daniela Nascimento Silva, Valentina Ancarani, Vittorio Sambri, Luana Calabro, Giovanni Martinelli, Massimiliano Mazza
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol
Monica Messina, Alfonso Piciocchi, Tiziana Ottone, Stefania Paolini, Cristina Papayannidis, Federica Lessi, Nicola Stefano Fracchiolla, Fabio Forghieri, Anna Candoni, Andrea Mengarelli, Maria Paola Martelli, Adriano Venditti, Angelo Michele Carella, Francesco Albano, Valentina Mancini, Bernardi Massimo, Valentina Arena, Valeria Sargentini, Mariarita Sciume, Domenico Pastore, Elisabetta Todisco, Giovanni Roti, Sergio Siragusa, Marco Ladetto, Stefano Pravato, Eleonora De Bellis, Giorgia Simonetti, Giovanni Marconi, Claudio Cerchione, Paola Fazi, Marco Vignetti, Sergio Amadori, Giovanni Martinelli, Maria Teresa Voso
CANCERS (2022)
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
Matteo Molica, Carla Mazzone, Pasquale Niscola, Ida Carmosino, Ambra Di Veroli, Cinzia De Gregoris, Fabrizio Bonanni, Salvatore Perrone, Natalia Cenfra, Luana Fianchi, Anna Lina Piccioni, Antonio Spadea, Giovanni Luzi, Andrea Mengarelli, Laura Cudillo, Luca Maurillo, Livio Pagano, Massimo Breccia, Luigi Rigacci, Paolo De Fabritiis
CANCERS (2022)
IMPACT OF PRE TRANSPLANT SALVAGE THERAPIES ON OUTCOME OF HODGKIN LYMPHOMA PATIENTS PERFORMING ALLOGENEIC TRANSPLANT
Fulvia Fanelli, Stefan Hohaus, Maria Cantonetti, Giuseppe Cimino, Elsa Pennese, Roberta Battistini, Eugenio Galli, Raffaella Cerretti, Anna Proia, Federica Fatone, Ida Provenzano, Elisabetta Abruzzese, Erica Finolezzi, Alessandro Pulsoni, Luigi Rigacci
CHEMOTHERAPY (2023)
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon
Andrea Ghelli Luserna di Rora, Mouna Jandoubi, Giovanni Martinelli, Giorgia Simonetti
MOLECULES (2023)
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William Blalock
NUTRIENTS (2023)
Detection of a Novel MSI2-C17orf64 Transcript in a Patient with Aggressive Adenocarcinoma of the Gastroesophageal Junction: A Case Report
Anna Ferrari, Roberto Fiocca, Elena Bonora, Chiara Domizio, Eugenio Fonzi, Davide Angeli, Gian Domenico Raulli, Sandro Mattioli, Giovanni Martinelli, Chiara Molinari
GENES (2023)
Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma
Arianna Orsini, Luca Mastracci, Isotta Bozzarelli, Anna Ferrari, Federica Isidori, Roberto Fiocca, Marialuisa Lugaresi, Antonietta D'Errico, Deborah Malvi, Erica Cataldi-Stagetti, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimaki, Luca Bottiglieri, Kausilia K. Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Rasanen, Giovanni Martinelli, Sandro Mattioli, Elena Bonora
CANCERS (2023)
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli, Ugo De Giorgi
CANCERS (2023)
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma
Gabriele Perrone, Luigi Rigacci, Sara Urru, Sofya Kovalchuk, Marco Brugia, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo, Silvia Birtolo, Alessandro Melosi, Simone Santini, Ida Landini, Giandomenico Roviello, Raffaella Santi, Alessandra Macciotta, Fulvio Ricceri, Alberto Bosi, Monica Bocchia, Mario Petrini, Enrico Mini, Stefania Nobili
CANCERS (2023)
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, Benedetta Puccini, Sara Veronica Usai, Federica Cavallo, Alberto Fabbri, Monica Balzarotti, Sabrina Pelliccia, Stefano Luminari, Elsa Pennese, Vittorio Ruggero Zilioli, Abdurraouf Mokhtar Mahmoud, Gerardo Musuraca, Dario Marino, Roberto Sartori, Barbara Botto, Guido Gini, Manuela Zanni, Stefan Hohaus, Giuseppe Tarantini, Leonardo Flenghi, Monica Tani, Alice Di Rocco, Michele Merli, Daniele Vallisa, Chiara Pagani, Luca Nassi, Daniela Dessi, Simone Ferrero, Emanuele Cencini, Patrizia Bernuzzi, Caterina Mammi, Luigi Marcheselli, Valentina Tabanelli, Michele Spina, Francesco Merli
BLOOD ADVANCES (2023)
Neuroradiology of acute pathologies in adults with hematologic malignancies: a pictorial review
Carlo A. Mallio, Caterina Bernetti, Gennaro Castiello, Emma Gangemi, Valeria Tomarchio, Ombretta Annibali, Luigi Rigacci, Johan Van Goethem, Paul M. Parizel, Bruno Beomonte Zobel, Carlo C. Quattrocchi
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2023)
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
Emanuele Cencini, Anna Sicuranza, Sara Ciofini, Alberto Fabbri, Monica Bocchia, Alessandro Gozzetti
CURRENT ONCOLOGY (2023)
How I Manage Chronic Lymphocytic Leukemia
Patrice Nasnas, Claudio Cerchione, Gerardo Musuraca, Giovanni Martinelli, Alessandra Ferrajoli
HEMATOLOGY REPORTS (2023)